Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems
Level 5 - mechanism / opinion, no new human data
Non-clinical environmental and engineering monitoring study; graded level 5 by design analogy.
OpenAlex W2144484736 · doi:10.1016/j.seppur.2010.11.020
What was done
Researchers measured the occurrence, persistence, and removal of 11 pharmaceuticals and two endocrine-disrupting chemicals across multiple treatment stages in a full-scale water recycling plant combining conventional primary and secondary wastewater treatment with microfiltration and reverse osmosis membrane facilities in Queensland, Australia.
What was found
Salicylic acid (11–38 μg/L) and bisphenol A (6–23 μg/L) had the highest influent concentrations. Primary and secondary treatment reduced concentrations of all analytes by approximately one order of magnitude, though gemfibrozil, primidone, and carbamazepine had lower removal efficiencies of 74–78%. Subsequent microfiltration and reverse osmosis further reduced concentrations by an order of magnitude. Total plant removal efficiency exceeded 97%, with product water concentrations below 0.1 μg/L for most compounds, except bisphenol A which was detected at up to 0.5 μg/L.
Why it matters
The study shows that combining secondary wastewater treatment with microfiltration and reverse osmosis effectively reduces pharmaceutical and endocrine-disruptor concentrations below 0.1 μg/L for industrial recycling, though trace amounts of bisphenol A can persist.
Limits
The abstract describes data from a single facility and does not report the total number of sampling events, sample replicates, or statistical variance. Results may not generalize to facilities with different influent chemistry or membrane configurations.
Cited by
- supports Reverse osmosis water filters remove microplastics, nanoplastics, BPA, phthalates, and chemical contaminants from water.